• Email Address: info@crispr-bte.com

Would CRISPR/Cas system lead the therapeutic management of Cancer, HIV and nCOVID-19 in the future?


CRISPR/Cas is one of the ground-breaking discoveries in the biotechnological domain. The possibility of precise genome editing offers the promise of a cure, where conventional therapeutics has achieved limited success. This review discusses the potential applications of the CRISPR/Cas system in the management of diseases such as cancer, HIV, and nCOVID-19, all of which have high mortality rates worldwide. The review not only intends to add to the existing knowledge of CRISPR/Cas applications but also to identify the domains which require further research and attention for CRISPR/Cas to become an unparalleled genetic editing technology.

Leave a Reply

Your email address will not be published.

You may use these <abbr title="HyperText Markup Language">html</abbr> tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>